On July 1, 2025, Predictive Oncology Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD., allowing the sale of up to $10 million worth of its common stock. The shares will be purchased at 96% of the lowest daily VWAP over three consecutive trading days. The company can issue up to 1,921,706 shares unless stockholder approval is obtained to exceed this limit or the average sale price is at least $0.83 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.